Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
You are here
Home
News by month %2 2019
News by month March 2019
PTCommunity News March 2019
Researchers Identify Possible New Therapy for Pancreatic Cancer
New Treatment for Acute Myeloid Leukemia Has Startling Results
FDA Approves Zulresso™ Injection for Postpartum Depression
Sunosi™ Approved for Excessive Daytime Sleepiness From Narcolepsy or Obstructive Sleep Apnea
Stroke Survivors Regain Movement With Video-Game Device
New Class of Drugs Could Halt Ovarian Cancer Cell Growth
Saracatinib Receives Orphan Drug Designation for Idiopathic Pulmonary Fibrosis
FDA Approves Tecentriq for Adults With Extensive-Stage Small Cell Lung Cancer
New Drug May Prevent Recurrence, Improve Survival in Ovarian Cancer
Johnson & Johnson Hit With $29 Million Verdict in Talc Cancer Case
New Generic Valsartan Approved
Rate of Dementia Deaths in U.S. Has More Than Doubled Since 2000, CDC Says
Experimental Drug Limits Muscle Damage from Heart Attack
Guardian Pharmacy Services Ordered to Halt Production of Compounded Drugs
FDA Issues Alert About Surgical Staplers and Implantable Surgical Staples
Tecentriq Approved As First Immunotherapy for Breast Cancer
FDA Urges Caution With Robotically Assisted Surgical Devices
After 12 Years, HIV Reportedly Cured in a Second Patient
New Therapy for Charcot-Marie-Tooth Disease Gets Orphan Drug Designation
New Compound Gets Orphan Drug Status for Huntington’s Disease
